{
    "2019-07-26": [
        [
            {
                "time": "2019-07-31",
                "original_text": "AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Q2",
                        "Earnings",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie Earnings: ABBV Stock Pops on Q2 Beat",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Stock",
                        "Pops",
                        "Q2",
                        "Beat"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "5 Things You Need to Know From AbbVie's Q2 Earnings Results",
                "features": {
                    "keywords": [
                        "Things",
                        "Know",
                        "AbbVie",
                        "Q2",
                        "Earnings",
                        "Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie (ABBV) Beets on Q2 Earnings & Sales, Raises EPS View",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Beats",
                        "Q2",
                        "Earnings",
                        "Sales",
                        "EPS",
                        "View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "Stock",
                        "Jumps"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Discontinued",
                        "Drug",
                        "Trial",
                        "Biogen",
                        "Stock",
                        "Falling"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie spotlights Allergan deal, new drugs as Humira sales wane",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Allergan",
                        "deal",
                        "new",
                        "drugs",
                        "Humira",
                        "sales",
                        "wane"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AstraZeneca (AZN) Jumps: Stock Rises 5.7%",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Jumps",
                        "Stock",
                        "Rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie (ABBV) Toppes Q2 Earnings and Revenue Estimates",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Tops",
                        "Q2",
                        "Earnings",
                        "Revenue",
                        "Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "AbbVie Reverses 4-Day Dive â€” But Its Biggest Moneymaker Is In Trouble",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Reverses",
                        "4-Day",
                        "Dive",
                        "Biggest",
                        "Moneymaker",
                        "Trouble"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}